Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Improvements in cancer survival in Northern Ireland

Improvements in cancer survival in Northern Ireland

Imatinib has ability to cure type of leukemia

Imatinib has ability to cure type of leukemia

Early stage drug shows promise against cancer cells from young patients

Early stage drug shows promise against cancer cells from young patients

Daisy compound used to attack cancer stem cells

Daisy compound used to attack cancer stem cells

New skin patch treatment for Alzheimer's approved by the European Commission

New skin patch treatment for Alzheimer's approved by the European Commission

Novel strategy to tackle acute myelogenous leukemia

Novel strategy to tackle acute myelogenous leukemia

Re-engineered human T cells effectively target and kill cancerous B cells

Re-engineered human T cells effectively target and kill cancerous B cells

Sexual function affected by stem cell transplant according to long-term study

Sexual function affected by stem cell transplant according to long-term study

JAK genes and cancer

JAK genes and cancer

Benefits and risks of breastfeeding

Benefits and risks of breastfeeding

IMPACT: Increasing clinical trial participation

IMPACT: Increasing clinical trial participation

Unique role for blood formation gene MLL identified

Unique role for blood formation gene MLL identified

Ultraconserved non-coding RNAs may be important in human cancer

Ultraconserved non-coding RNAs may be important in human cancer

Congestive heart failure is rare among leukemia patients who take imatinib

Congestive heart failure is rare among leukemia patients who take imatinib

Revlimid receives approval in Switzerland for treatment of multiple myeloma

Revlimid receives approval in Switzerland for treatment of multiple myeloma

Genetics of imatinib resistance in acute lymphoblastic leukemia

Genetics of imatinib resistance in acute lymphoblastic leukemia

Biologic treatment for rheumatoid arthritis and the risk of cancer

Biologic treatment for rheumatoid arthritis and the risk of cancer

Fingolimod shows promise in 2 lethal leukemias

Fingolimod shows promise in 2 lethal leukemias

FDA grants orphan drug designation to TREANDA

FDA grants orphan drug designation to TREANDA

St. Jude discovers factors that accelerate resistance to Gleevec targeted therapy in lymphoblastic leukemia

St. Jude discovers factors that accelerate resistance to Gleevec targeted therapy in lymphoblastic leukemia